The PLOS One Editors retract this article [1] due to concerns about peer review integrity, authorship, and potential manipulation of the publication process. These concerns call into question the validity of the reported results. We regret that the issues were not identified prior to the article’s publication.
SG agreed with the retraction. MSM responded but expressed neither agreement nor disagreement with the editorial decision. MTI, WB, MSH, MSSR, IB, and YAM either did not respond directly or could not be reached.
Reference
Citation: The PLOS One Editors (2025) Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer’s disease treatment. PLoS One 20(5): e0324094. https://doi.org/10.1371/journal.pone.0324094
Published: May 8, 2025
Copyright: © 2025 The PLOS One Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.